التقييس لدول مجلس التعاون لدول الخليج العربية  هيئة   
GCC STANDARDIZATION ORGANIZATION (GSO)  
 
 
مشروع تحديث لائحةأولي  
First Draft of Standard DS  
 
 
 
 
TC05 -2إعداد اللجنة الفرعية الخليجية رقم  
 
Prepared by GSO Technical Sub-Committee No. TC05 -2 
 
 
تحديث  
GSO 2481  / 2019 
 
 
الحدود القصوى المسموح بها من بقايا الادوية البيطرية في الاغذية  
Maximum  Residues Limits (Mrls) of Veterinary Drugs In Food 
 
 
 
 
 
 
I.C.S: 67.040.00  
هذه الوثيقة مشروع لمواصفة قياسية خليجية تم 
توزيعها لإبداء الرأي والملحوظات بشأنها، لذلك فإن ها 
عرضة للتغيير والتبديل،  ولا يجوز الرجوع إليها 
كمواصفة قياسية خليجية إلا بعد اعتمادها من الهيئة. This document is a draft GSO Standard 
circulated for comments. It is, therefore ,  
subject to alteration and modification and 
may not be referred to as a GSO Standard 
until approved by GSO .  
 
 
 
 
 
 
 
 
   تقديم 
هيئة التقييس لدول مجلس التعاون لدول الخليج العربية هيئة إقليمية تضم في عضويتها أجهزة  
التقييس الوطنية  في الدول  الأعضاء ، ومن مهام الهيئة إعداد المواصفات  القياسية واللوائح  
الفنية الخليجية بواسطة لجان فنية متخصصة . 
 
قرر (المجلس الفني لـ/مجلس إدارة) هيئة التقييس لدول مجلس التعاون لدول الخليج  العربية في 
اجتماعه رقم () الذي عقد بتاريخ / /  هـ ،الموافق  /  /  م اعتماد تحديث (اللائحة الفنية) ا لخليجية  
(GSO 2481  الحدود القصوى المسموح بها من بقايا الادوية البيطرية في الاغذية) باللغة 
(العربية/الإنجليزية) التي تم دراستها وإعدادها ضمن برنامج عمل (اللجنة الفنية ) الخليجية رقم  
TC05-2"   "اللجنة الفنيـة الفرعية الخليجية لمواصفات المواد المضافة وملوثات ا لأغذية " 
المدرجة في خطة (المملكة العربية السعودية ). 
على أن تلغي المواصفة القياسية/اللائحة الفنية الخليجية رقم   (2481  ) وَتحل محلها. 
 
 
 
 
 1 
  الحدود القصوى المسموح بها من بقايا الادوية البيطرية في الاغذية 
 
 
1    المجال:  
تختص هذه المواصفة القياسية الخليجية بالحدود القصوى المسموح بها لمتبقيات الأ دوية 
البيطرية في المنتجات الغذائية والغذاء من أصل حيواني. 
2    المراجع التكميلية 
1.2 GSO 592         " طرق أخذ عينات اللحوم ومنتجاتها " .                                                         
2.2   GSO 2475  "طرق أخذ العينات لتقدير بقايا الأدوية البيطرية في الأغذية-الجزء الأول: 
منتجات اللحوم والدواجن " .   
3.2  المواصفة القياسية الخليجية التي تعتمدها الهيئة والخاصة بـ " طرق تقدير بقايا العقاقير 
البيطرية في اللحوم ومنتجات اللحوم" .                    
     3التعاريف 
1.3  الدواء البيطري : هو أي مادة توصف أو تطبق أو تعطى لأي حيوان منتج للغذاء مثل الحيوانات
المنتجة للحوم أو الحليب, الدواجن, الأسماك سواء كان استخدامها لأغراض علاجية  وقائية أو 
تشخيصية أو كمحفزات للنمو .  
2.3  متبقيات الأدوية البيطرية : وهي المواد التي تتواجد  في المنتجات الغذائية من أصل حيواني 
كنتيجة لاستخدام الأدوية البيطرية. وهذه تعتمد على المركبات الأصلية و/أو نوا تج أيضها داخل  
الجسم وكذلك بقايا الأدوية البيطرية غير النقية. 
3.3  الحدود القصوى للمتبقيات : هو الحد الأقصى المسموح لمتبقي دواء بيطري ناتج من رعاية 
حيوانية وبيطرية جيدة وموصى به من هيئة الدستور الغذاء والهيئات الدولية الأخ رى وذل ك 
ليكون حد قانوني مسموح به في الغذاء أو مضافاً إليه. يعبر عن هذه الحدود كتركيزات تق اس 
بالمايكرو جرام من البقايا للكيلو غرام من المادة الغذائية (مكجم/كجم) (µg/kg) . 
        4.3  المعدل المسموح تناوله يومياً  : هو الكمية المتبقية من الدواء البيطري ، التي تحسب على أساس 
وزن الجسم، والتي يمكن تناولها يوميا على مدى عمر الإنسان دون أي مخاطر صحية  معتبرة  
(متوسط وزن الإنسان 60 كجم 
4-  المتطلبات : 
 يجب أن لا تتعدى بقايا الأدوية البيطرية في الأغذية ذات الأصل الحيواني حدود معينة والتي تم 
توصيف كل منها في الجداول التالية : 
 
 
 
 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
2 
 5-  قائمة الأدوية البيطرية 
Veterinary Drugs List:  
Abamectin  ................................ ................................ ................................ ................................ .....................  4 
Albendazole  ................................ ................................ ................................ ................................ ..................  5 
Amoxi cillin  ................................ ................................ ................................ ................................ ...................  5 
Ampicillin  ................................ ................................ ................................ ................................ .....................  6 
Amprolium  ................................ ................................ ................................ ................................ ....................  6 
Apramycin  ................................ ................................ ................................ ................................ ....................  7 
Arsanilic acid  ................................ ................................ ................................ ................................ ...............  8 
Atropine sulfate  ................................ ................................ ................................ ................................ ...........  8 
Avermectin  ................................ ................................ ................................ ................................ ...................  9 
Avilamycin  ................................ ................................ ................................ ................................ ...................  9 
Bacitracin  ................................ ................................ ................................ ................................ ....................  10 
Benzyl  ................................ ................................ ................................ ................................ ..........................  11 
Bromhexine  ................................ ................................ ................................ ................................ ................  12 
Carprofen  ................................ ................................ ................................ ................................ ....................  12 
Cefalonium  ................................ ................................ ................................ ................................ .................  12 
Cefapirin  ................................ ................................ ................................ ................................ ......................  13 
Ceftiofur  ................................ ................................ ................................ ................................ ......................  13 
Cefuroxime  ................................ ................................ ................................ ................................ .................  14 
Chlortetracycline/Oxytetracycline/Tetracycline  ................................ ................................ .................  14 
Clazuril  ................................ ................................ ................................ ................................ ........................  15 
Clenbuterol  ................................ ................................ ................................ ................................ .................  15 
Clopidol  ................................ ................................ ................................ ................................ .......................  15 
Cloprostenol  ................................ ................................ ................................ ................................ ...............  16 
Closantel  ................................ ................................ ................................ ................................ ......................  16 
Cloxacillin  ................................ ................................ ................................ ................................ ...................  16 
Colistin  ................................ ................................ ................................ ................................ ........................  16 
Cyfluthrin  ................................ ................................ ................................ ................................ ....................  17 
Cyhalothrin  ................................ ................................ ................................ ................................ .................  18 
Cypermethrin And Alpha -Cypermethrin  ................................ ................................ ..............................  18 
Danofloxacin  ................................ ................................ ................................ ................................ ..............  18 
Decoquinate  ................................ ................................ ................................ ................................ ................  19 
Deltamethrin  ................................ ................................ ................................ ................................ ...............  19 
Derquantel  ................................ ................................ ................................ ................................ ...................  20 
Dexamethasone  ................................ ................................ ................................ ................................ ..........  20 
Diazinon (Ectoparasiticides  ................................ ................................ ................................ ....................  21 
Diclazuril  ................................ ................................ ................................ ................................ .....................  21 
Diclofenac  ................................ ................................ ................................ ................................ ...................  22 
Difloxacin  ................................ ................................ ................................ ................................ ...................  22 
Dihydrostreptomycin/ streptomycin  ................................ ................................ ................................ ...... 22 
Diminazene  ................................ ................................ ................................ ................................ .................  23 
Dinitolmide  ................................ ................................ ................................ ................................ .................  23 
Doramectin  ................................ ................................ ................................ ................................ .................  24 
Doxapram  ................................ ................................ ................................ ................................ ....................  25 
Doxycycline  ................................ ................................ ................................ ................................ ................  25 
Emamectin Benzoate  ................................ ................................ ................................ ................................  26 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
3 
 Enrofloxacin  ................................ ................................ ................................ ................................ ...............  26 
Epinephrine  ................................ ................................ ................................ ................................ .................  27 
Eprinomectin  ................................ ................................ ................................ ................................ ..............  27 
ERYTHROMYCIN  ................................ ................................ ................................ ................................ .. 28 
ESTRADIOL -17BETA  ................................ ................................ ................................ ............................  28 
Etamiphylline camsilat  ................................ ................................ ................................ .............................  28 
FEBANTEL/FENBENDAZOLE/OXFENDAZOLE  ................................ ................................ ........  28 
Florfenicol  ................................ ................................ ................................ ................................ ...................  29 
FLUAZURON  ................................ ................................ ................................ ................................ ...........  29 
FLUBENDAZOLE  ................................ ................................ ................................ ................................ ... 30 
FLUMEQUINE  ................................ ................................ ................................ ................................ .........  31 
Flunixin meglumine  ................................ ................................ ................................ ................................ .. 31 
GENTAMICIN  ................................ ................................ ................................ ................................ ..........  32 
GONADOTROPHIN  ................................ ................................ ................................ ...............................  32 
HALOFUGINONE HYDROBROMIDE  ................................ ................................ .............................  32 
HYDROCHLOROTHIAZIDE  ................................ ................................ ................................ ...............  33 
IMIDOCARB  ................................ ................................ ................................ ................................ .............  33 
ISOMETAMIDIUM  ................................ ................................ ................................ ................................ . 33 
IVERMECTIN  ................................ ................................ ................................ ................................ ...........  33 
KETAMINE  ................................ ................................ ................................ ................................ ...............  34 
KETOPROFEN  ................................ ................................ ................................ ................................ .........  34 
LASALOCID SODIUM  ................................ ................................ ................................ ..........................  35 
LEVAMISOLE  ................................ ................................ ................................ ................................ ..........  36 
LINCOMYCIN  ................................ ................................ ................................ ................................ ..........  36 
LUFENURON  ................................ ................................ ................................ ................................ ...........  37 
MADURAMICIN AMMONIUM  ................................ ................................ ................................ .........  37 
MARBOFLOXACIN  ................................ ................................ ................................ ...............................  37 
MEBENDAZOL ................................ ................................ ................................ ................................ ........  38 
MELENGESTROL ACETATE  ................................ ................................ ................................ .............  38 
MEBENDAZOL ................................ ................................ ................................ ................................ ........  38 
Methyl benzoq uate  ................................ ................................ ................................ ................................ .... 39 
MONENSIN  ................................ ................................ ................................ ................................ ...............  39 
MONEPANTEL  ................................ ................................ ................................ ................................ ........  40 
MOXIDECTIN  ................................ ................................ ................................ ................................ ..........  40 
NARASIN  ................................ ................................ ................................ ................................ ...................  41 
NATAMYCIN  ................................ ................................ ................................ ................................ ...........  41 
NEOMYCIN  ................................ ................................ ................................ ................................ ..............  41 
NICARBAZ IN ................................ ................................ ................................ ................................ ...........  43 
NITOBIMIN ................................ ................................ ................................ ................................ ...............  43 
NITROXYNIL  ................................ ................................ ................................ ................................ ...........  43 
NITROXYNIL  ................................ ................................ ................................ ................................ ...........  44 
NYSTATIN  ................................ ................................ ................................ ................................ ................  44 
OLEANDOMYCIN  ................................ ................................ ................................ ................................ .. 44 
ORMETOPRIM ................................ ................................ ................................ ................................ .........  45 
OXY CLOZANIDE  ................................ ................................ ................................ ................................ ... 45 
OXYTETRACYCLINE  ................................ ................................ ................................ ...........................  45 
OXYTOCIN  ................................ ................................ ................................ ................................ ...............  46 
PERMETHRIN  ................................ ................................ ................................ ................................ ..........  46 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
4 
 PHOXIM  ................................ ................................ ................................ ................................ .....................  47 
PIPERAZINE  ................................ ................................ ................................ ................................ .............  47 
Pirlimycin  ................................ ................................ ................................ ................................ ....................  47 
POLOXALENE  ................................ ................................ ................................ ................................ .........  48 
POLYMIXIN  ................................ ................................ ................................ ................................ .............  48 
PRAZEQUANTEL  ................................ ................................ ................................ ................................ ... 48 
PREDNISOLONE  ................................ ................................ ................................ ................................ .... 48 
PROCAINE BENZYL PENICILLIN  ................................ ................................ ................................ ... 49 
Procaine HCl  ................................ ................................ ................................ ................................ ..............  49 
PROGESTERONE  ................................ ................................ ................................ ................................ ... 49 
RACTOPAMINE  ................................ ................................ ................................ ................................ ...... 49 
RAFOXANIDE  ................................ ................................ ................................ ................................ .........  50 
ROBENIDINE HYDROCHLORIDE  ................................ ................................ ................................ ... 50 
ROXARSONE  ................................ ................................ ................................ ................................ ...........  50 
SALINOMYCIN  ................................ ................................ ................................ ................................ ....... 51 
SARAFLOXACIN  ................................ ................................ ................................ ................................ .... 51 
SEMDURAMICIN  ................................ ................................ ................................ ................................ ... 51 
SPECTINOMYCIN  ................................ ................................ ................................ ................................ .. 52 
SPIRAMYCIN  ................................ ................................ ................................ ................................ ...........  52 
STREPTOMYCIN  ................................ ................................ ................................ ................................ .... 53 
SULFADIMIDINE  ................................ ................................ ................................ ................................ ... 53 
TEFLUBENZURON  ................................ ................................ ................................ ................................  54 
TESTOSTERONE  ................................ ................................ ................................ ................................ .... 54 
TETRACYCLINE  ................................ ................................ ................................ ................................ .... 54 
THIABENDAZOLE  ................................ ................................ ................................ ................................ . 56 
THIAMPHENICOL  ................................ ................................ ................................ ................................ . 57 
TIAMULIN  ................................ ................................ ................................ ................................ ................  57 
TILMICOSIN ................................ ................................ ................................ ................................ .............  58 
TOLFENAMIC ................................ ................................ ................................ ................................ ..........  58 
TOLTRAZURIL ................................ ................................ ................................ ................................ ........  58 
TRENBOLONE ................................ ................................ ................................ ................................ .........  59 
TRICAINE METHANESULFONATE  ................................ ................................ ................................  59 
TRICHLORFON  ................................ ................................ ................................ ................................ ....... 59 
TRICLABENDAZOLE  ................................ ................................ ................................ ...........................  59 
TRIMETHOPRIM  ................................ ................................ ................................ ................................ .... 60 
TRIMETHOPRIM  ................................ ................................ ................................ ................................ .... 60 
TYLOSIN  ................................ ................................ ................................ ................................ ...................  60 
VIRGINIAMYCIN  ................................ ................................ ................................ ................................ ... 61 
ZERANOL  ................................ ................................ ................................ ................................ ..................  61 
ZILPATEROL  ................................ ................................ ................................ ................................ ...........  61 
 
 
6- الحدود القصوى المسموح بها من بقايا الأدوية البيطرية في الأغذية  : 
Abamectin  (Anthelmintic agent    (مضاد الديدان   
Acceptable Daily Intake (ADI)   0-2 µg/kg body weight  
Residue Definition  Avermectin B1a 
Species Tissue MRL (μg/kg) Referance Notes مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
5 
 Cattle  Liver  100 
CAC 26 (2003)  
  
Kidney  50  
Fat 100  
 
Albendazole  (Anthelmintic agent    (مضاد الديدان   
Acceptable Daily Intake (ADI)   0-50 µg/kg body weight  
Residue  Definition  Exp milk, 2 -aminosulfone metabolite: milk not yet 
identified   
Species Tissue MRL (μg/kg) Refe rance  Notes 
Not specified  Muscle  100 
CAC 20 (1993)  
  
Liver  5000   
Kidney  5000   
Fat 100  
Milk 
(μg/l)  100  
 
Amoxicillin  (Antimicrobial agent    (مضاد الميكروبات   
Microbiologicale 
Acceptable Daily Intake 
(ADI)   0-0.002 mg/kg body weight based on the effects of Amoxicillin 
on the intestinal microbiota  
Acute Reference Dose  0.005  mg/kg bw based on microbiological effects on the 
intestinal microbiota  
Estimated Chronic 
Dietary Exposure  0.14 μg/kg bw per day (for the general population), which 
repres ents 7% of the upper bound of the mADI  
Estimated Acute Dietary 
Exposure  1.4 μg/kg bw (for the general population), which represents 
28% of the microbiological ARfD  
1.6 μg/kg bw (for children), which represents 31% of the 
microbiological ARfD  
Residue Defi nition  Amoxicillin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 
CAC 35 (2012)  
  
Liver  50  
Kidney  50  
Fat 50  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
6 
 Milk  4  
Sheep  Muscle  50  
Liver  50  
Kidney  50  
Fat 50  
Milk  4  
Finish  Fillet  50 CAC 41 (2018)  
 The term  “finfish”includes all 
fish species.  
Muscle plus skin in natural 
proportion   
Muscle  50 The term “finfish”includes all 
fish species.  
 
Ampicillin  (Antimicrobial agent    (مضاد الميكروبات   
Acceptable Daily Intake 
(ADI)   100 ug/kg body weight  
 
Acute Refe rence Dose  0.012 mg/kg bw based on the microbiological end -point.  
Estimated Chronic 
Dietary Exposure  0.29 μg/kg bw per day (for the general population), which 
represents 10% of the upper bound of the ADI.  
Estimated Acute Dietary 
Exposure  1.9 μg/kg bw pe r day (for the general population), which 
represents 16% of the ARfD.  
1.7 μg/kg bw per day (for children), which represents 14% of 
the ARfD.  
Residue Definition  Ampicillin 
Species Tissue MRL (μg/kg) Referance Notes 
Finish  Fillet  50 CAC 41 (2018)  
 The te rm “finfish”includes all 
fish species.  
Muscle plus skin in natural 
proportion   
Muscle  50 The term “finfish”includes all 
fish species.  
 
Amprolium  (Anticoccidial drugs      (مضاد الطفيليات   
Acceptable Daily Intake 
(ADI)   100 ug/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  500 Canadian MRL, 
2011   
Liver  500  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
7 
 Kidney  500  
Fat 2000   
Chicken  Muscle  200 
EMEA/MRL/76
7/00-FINAL 
(2001)   
Liver  200  
Kidney  400  
 Skin/fat  200 
  
Eggs  1000   
Turkey  Muscle  200 
 
 
EMEA/MRL/7 6
7/00-FINAL 
(2001)   
Liver  200  
Kidney  400  
Skin/fat  200  
 
Apramycin  (Aminoglycosides Antibiotics (مضاد البكتريا   
Acceptable Daily Intake 
(ADI)   0–30  μg/kg  body weight  
 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 
 
Australian 
standard MRL, 
2012   
Liver  2000   
Kidney  20000   
Fat 2000   
Sheep  Muscle  50 
 
Australian 
standard MRL, 
2012   
Liver  2000   
Kidney  2000   
Fat 2000   
Goat  Muscle  50  
 
Australian 
standard MRL, 
2012   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
8 
 Liver  2000  
  
 Kidney  2000   
Fat 2000   
Came l Muscle  50 
Australian 
standard MRL, 
2012   
Liver  2000   
Kidney  2000   
Fat 2000   
Chicken  Muscle  50 
Australian 
standard MRL, 
2012   
Liver  1000   
Kidney  1000   
Fat 1000   
Turkey  Muscle  50 
Australian 
standard MRL, 
2012   
Liver  1000   
Kidney  1000  
Fat 1000   
 
Arsanilic acid  (Growth Promoting Agents  (محفزات النمو   
Acceptable Daily Intake 
(ADI)   not established  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  500 Canadian MRL, 
2011   
 Liver  2000  
  
Eggs  500  
Turkey  Muscle  500 Canadian 
MRL(2011)  
  
Liver  2000   
 
Atropine sulfate  (Digestive System Drugs   (أدوية الجهاز الهضمي  
Acceptable Daily Intake 0-0.0002 mg/kg body weight  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
9 
 (ADI)   
Species Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species  Not 
applica
ble  
No MRL r equired  Commission 
Regulation (Eu) 
No 37/2010   
 
Avermectin  (Aminoglycosides Antibiotics (مضاد البكتريا   
Acceptable Daily Intake 
(ADI)   0 -2 μg/kg body weight  
 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  5 Australian 
standard MRL, 
2012   
Liver  100 
 
CAC/MRL 2 -
2011   
Kidney  50  
Fat 100  
Milk 
(µg/l)  20 Australian 
standard MRL, 
2012   
Sheep  Muscle  20 EMEA/MRL/86
5/03-FINAL 
June 2004   
Liver  50 
Australian 
standard MRL, 
2012   
 Kidney  50  
Fat 50  
Goat  Muscle  10 
 
 
Australian 
standard  MRL, 
2012   
Liver  50  
Kidney  10  
Fat 100  
Milk  5  
 
Avilamycin  (Antimicrobial Drugs    (مضادالميكروبات   
Acceptable Daily Intake (ADI)   0-50 µg/kg body weight  
Residue Definition  Exp milk, 2 -aminosulfone metabolite: milk not yet 
identified   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
10 
 Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  100 
CAC 32 (2009)  
  
Liver  5000   
Kidney 5000   
Fat 100  
Turkey  Muscle  200 
CAC 32 (2009)  
  
Liver  300  
Kidney  200  
Fat/skin  200  
Rabbits  Muscle  200 
CAC 32 (2009)  
  
Liver  300  
Kidney  200  
Fat/skin  200  
 
Bacitracin  (Antimicrobial Drugs    (مضاد الميكروبات   
Acceptable Dail y Intake 
(ADI)   0-1 mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Camel  Milk(μg/l)  500 
Australian 
standard MRL, 
2012  
Canadian MRL, 
2011   
Chicken  
 
 
 
 Muscle  500  
Liver  500  
Kidney  500  
Fat 500  
Eggs  500   
Turkey  
 Muscle  500 
Canadian MRL, 
2011  
  
Liver  500  
Kidney  500  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
11 
 Fat 500  
 
Benzyl  penicillin  (Antimicrobial Agent    (مضادالميكروبات   
Acceptable Daily Intake (ADI)   30 μg penicillin/person/day  
Residue Definition  Benzylpenicillin 
Species Tissue MRL (μg/kg) Referance Notes 
Catle  Muscle  50 
CAC 23 (1999)  
  
Liver  50  
Kidney  50  
Milk μg/l  4  
Chicken  Muscle  50 CAC 32 (2009)  
 Applies to procaine 
benzylpenicillin 
only.  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
12 
  
 
Liver  50 
 Applies to procaine 
benzylpenicillin 
only.  
Kidney  50 Applies to procaine 
benz ylpenicillin 
only.  
 
Bromhexine  (RESPIRATORY SYSTEM DRUGS  (أدوية الجهازالتنفسي   
Acceptable Daily Intake 
(ADI)   0.3 mg /kg per person  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle   
Not 
applicable  No MRL required  Commission 
regulation (EU) 
No 37/2010   
Poultry  Not 
applicable  No MRL required   
 
Carprofen  (Anti-Inflammatories  (مضادات الالتهابات الغير ستيرودية  
Acceptable Daily Intake 
(ADI)   8.6 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  500 
Commission 
regulation (EU) 
No 37/2010  
Emea/mrl/042/9
5  
Liver  1000   
Kidney  1000   
Fat 1000   
 
Cefalonium  (Antimicrobial Agent    (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)   0 - 20 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
Australian 
standard MRL, 
2012   
Liver  100  
Kidney  100  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
13 
 Fat 100  
Milk 
(µg/l)  20  
 
Cefapirin  (Antimicrobial Agent    (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)   0 - 0.02 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  20 Australian 
standard MRL, 
2012   
Liver  20  
 Kidney  20 
  
Fat 20  
Milk 
(µg/l)  10  
 
Ceftiofur  (Antimicrobial Agent    (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)   0 - 50 μg/kg body weight  
Residue Definition  Desfuroylceftiofur 
Species Tissue MRL (μ g/kg)  Referance Notes 
Cattle  Muscle  1000  
CAC 23 (1999)  
  
Liver  2000   
Kidney  6000   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
14 
  
 Fat 2000  
  
Milk 
(µg/l)  100  
 
Cefuroxime  (Antimicrobial Agent    (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)   0 - 30 μg/kg body weight  
Species Tissue MRL (μ g/kg)  Referance Notes 
Cattle  Muscle  100 
Australian 
standard MRL, 
2012   
Liver  100  
Kidney  100  
Fat 100  
Milk 
(µg/l)  100  
 
Chlortetracycline/Oxytetracycline/Tetracycline  (Antimicrobial Drugs    
(مضادالميكروبات  
Acceptable Daily Intake (ADI)   0-30 µg/kg body weight  
Residue Definition  Parent drugs, singly or in combination 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  200 
CAC 26 
(2003)  
  
Liver  600  
Kidney  1200   
Milk 
(µg/l)  100  
Sheep  Muscle  200 
CAC 26 
(2003)  
  
Liver  600  
Kidney  1200   
Milk 
(µg/l)  100  
Poultry  Muscle  200 
CAC 26 
(2003)  
  
Liver  600  
Kidney  1200   
Eggs  400  
Fish 
Muscle  200 CAC 26 
(2003)  
 Applies only to 
oxytetracycline  
Giant prawn Muscle  200 CAC 26 Applies only to مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
15 
 (Paeneus monodon)  (2003)  
 oxytetracycline  
 
Clazuril  (Growth Promoting Agent  (محفز النمو  
Acceptable Daily Intake 
(ADI)  0.05 mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Pigeon  No MRL 
required   
Not applicable  Commission 
Regulation (Eu) 
No 37/2010   
 
Clenbuterol  (adrenoceptor agonist    (مضاد البكتريا  
Acceptable Dai ly Intake (ADI)  0-0.004 µg/kg body weight  
Residue Definition  Clenbuterol 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  0.2 
CAC 26 
(2003)  
 Due to the potential 
abuse of this drug, the 
MRLs are 
recommended only 
when associated with 
a nationally  approved 
therapeutic use, such 
as tocolysis or as an 
adjunt therapy in 
respiratory diseases  Liver  0.6 
Kidney  0.6 
Fat 0.2 
Milk 
(µg/l)  0.05 
Horse  Muscle  0.2 
CAC 26 
(2003)  
 Due to the potential 
abuse of this drug, the 
MRLs are 
recommended on ly 
when associated with 
a nationally approved 
therapeutic use, such 
as tocolysis or as an 
adjunt therapy in 
respiratory diseases  Liver  0.6 
Kidney  0.6 
Fat 0.2 
 
Clopidol  (Antiparasitic Drugs   (مضاد الطفيليات  
Acceptable Daily Intake 
(ADI)  0.0025 mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  5000   
Canadian MRL, 
2011   
Liver  15000   
Kidney  15000   
Turkey  Muscle  5000    مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
16 
 Liver  15000  Canadian MRL, 
2011   
Kidney  15000   
 
Cloprostenol  (Hormones  (الهرمونات  
Acceptable Daily Intake 
(ADI)  0.075 μg/kg  per person  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Edible  
tissues  No need to  
establish  Annex 11of  
Council regulation  
(EEC)No 2377/90   
 
Closantel  (Anthelmin tic agents   (مضاد الديدان  
Acceptable Daily Intake 
(ADI)  0-30 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  1000  
 
CAC 20 (1993)  
  
Liver  1000   
Kidney  3000   
Fat 3000   
Sheep  Muscle  1500  
CAC 20 (1993)  
  
Liver  1500   
Kidney  5000   
Sheep  Fat 2000  CAC 20 (1993)  
  
 
Cloxacillin  (Antimicrobial agents   (مضادالميكروبات  
Acceptable Daily Intake (ADI)  200 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  10  
 
Canadian MRL, 
2011   
Liver  10  
Kidney  10  
Fat 10  
Milk (µg/l)  10 Australian 
standard MRL, 
2012   
 
Colistin  (Antimicrobial Drugs    (مضادالميكروبات  
Acceptable Daily Intake (ADI)  0-7 µg/kg body weight  
Residue Definition  Sum of colistin A and colistin B 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  150 CAC 31 
(2008)   
Liver  150  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
17 
 Kidney  200  
Fat 150  
Milk 
(µg/l)  50  
Sheep  Muscle  150 
CAC 31 
(2008)   
Liver  150  
Kidney  200  
Fat 150  
Milk 
(µg/l)  50  
Goat  Muscle  150 
CAC 31 
(2008)   
Liver  150  
Kidney  200  
Fat 150  
Chicken  Muscle  150 
CAC 31 
(2008)   
Liver  150  
Kidney  200  
Fat 150 The MRL includes 
skin + fat  
Eggs  300  
Tukey  Muscle  150 
CAC 31 
(2008)   
Liver  150  
Kidney  200  
Fat 150 The MRL includes 
skin + fat  
Rabbit  Muscle  150 CAC 31 
(2008)   
 Liver  150   
Kidney  200  
Fat 150  
 
Cyfluthrin  (insecticide    (مبيد حشري  
Acceptable Daily Intake (ADI)  0-20 µg/kg body weight  
Residue Definition  Cyfluthrin 
Species  Tissue  MRL (μg/kg)  Referance  Notes  
Cattle  Muscle  20 
CAC 26 
(2003)  
Liver  20  
Kidney  20  
Fat 200  
Milk 
(µg/l)  40  
 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
18 
 Cyhalothrin  (insecticide    (مبيد حشري  
Acceptable Daily Intake (ADI)  0-5 µg/kg body weight  
Residue Definition  Cyhalothrin  
Species  Tissue  MRL (μg/kg)  Referance  Notes  
Cattle  Muscle  20 
CAC 28 
(2005)  
Liver  20  
Kidney  20  
Fat 400  
Milk 
(µg/l)  30  
Sheep  Muscle  20 
CAC 28 
(2005)   
Liver  50  
Kidney  20  
Fat 400  
 
Cypermethrin And Alpha -Cypermethrin  (insecticide    (مبيد حشري  
Acceptable Daily Intake (ADI)  0-20 µg/kg body weight for b oth Cypermethrin And 
Alpha -Cypermethrin  
Residue Definition  Total of cypermethrin residues resulting from the use of 
cypermethrin or alpha -cypermethrin as veterinary drugs  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 
CAC 29 
(2008)   
Liver  50  
Kidney  50  
Fat 1000  
Milk 
(µg/l)  100  
Sheep  Muscle  50 
CAC 29 
(2008)   
Liver  50  
Kidney  50  
Fat 1000   
 
Danofloxacin  (Antimicrobial Drugs    (مضادالميكروبات  
Acceptable Daily Intake (ADI)  0-20 µg/kg body weight  
Residue Definition  Danofloxacin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  200 
CAC 24 
(2001)   
Liver  400  
Kidney  400  
Fat 100  
Shicken  Muscle  200 CAC 24 
(2001)   
Liver  400  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
19 
 Kidney  400  
Fat 100 Fat/skin in normal 
proportion  
 
Decoquinate  (Antipa rasitic Drugs      (مضاد الطفيليات  
Acceptable Daily Intake (ADI)  0-7 µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  1000  
Canadian 
MRL, 2011   
Liver  2000   
Kidney  2000   
Fat 2000   
Goat  Muscle  1000  Canadian 
MRL, 2011  
  
Liver  2000   
 Kidney  2000    
Fat 2000   
Chicken  Muscle  1000  
Canadian 
MRL, 2011  
  
Liver  2000   
Kidney  2000   
Fat 2000   
 
Deltamethrin  (insecticide    (مبيد حشري  
Acceptable Daily Intake (ADI)  0-10 µg/kg body weight  
Residue Definition  Deltamethrin  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  30 CAC 26 
(2003)   
Liver  50  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
20 
  
 Kidney  50   
Fat 500  
Milk 
(µg/l)  30  
Chicken  Muscle  30 
CAC 26 
(2003)   
Liver  50  
Kidney  50  
Fat 500  
Eggs  30  
Salmon  Muscle  30 CAC 26 
(2003)   
Sheep  Muscle  30 
CAC 26 
(2003)   
Liver  50  
Kidney  50  
Fat 500  
 
Derquantel  (Anthelmintic agents   (مضاد الديدان  
Acceptable Daily Intake (ADI)  0-0.3 µg/kg body weight  
Residue Definition  Derquantel  
Species Tissue MRL (μg/kg) Referance Notes 
Shee p Muscle  0.3 
CAC 38 
(2015)   
Liver  0.8  
Kidney  0.4  
Fat 7  
 
Dexamethasone  (glucocorticosteroid   (مضادات الالتهابات الستيرودية  
Acceptable Daily Intake (ADI)  0-0.015 µg/kg body weight  
Residue Definition  Dexamethasone  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  1 
 CAC 32 
(2009)   
Liver  2  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
21 
  
 Kidney  1   
Milk 
(µg/l)  0.3  
Horses  Muscle  1 
CAC 32 
(2009)   
Liver  2  
Kidney  1  
 
Diazinon (Ectoparasiticides     (مضادات الطفيليات الخارجية  
Acceptable Daily Intake (ADI)  0–0.002 mg/kg  body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  
20  
 
 
Commission 
regulation (EU) 
No 37/2010   
Liver  
20  
Kidney  
20  
Fat 
700  
Milk 
(µg/l)  20  
 
 
Diclazuril  (antiprotozoal agent   (مضادات الطفيليات  
Acceptable Daily Intake ( ADI)  0-0.30 µg/kg body weight  
Residue Definition  Diclazuril  
Species Tissue MRL (μg/kg) Referance Notes 
poultry  Muscle  500 
 
CAC 23 
(1999)   
Liver  3000   
Kidney  2000   
Fat/skin  1000   
Rabbit  Muscle  500 
CAC 23 
(1999)   
Liver  3000   
Kidney  2000   
Fat 1000   
Sheep  Muscle  500 
CAC 23 
(1999)   
Liver  3000   
Kidney  2000   
Fat 1000   
 
 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
22 
 Diclofenac  (Anti-Inflammatories non Steroidal    (مضادات الالتهابات غير الستيرودية  
Acceptable Daily Intake (ADI)  0.5 μg/kg  body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  
5  
 
 
Commission 
regulation (EU) 
No 37/2010   
Liver  
5  
Kidney  
10  
Fat 
1  
Milk 
(µg/l)  0.1  
 
 
 
Difloxacin  (Antimicrobial Drugs    (مضاد الميكروبات  
Acceptable Daily Intake (ADI)  10 µg/kg body weight  
Species Tissue MRL  (μg/kg)  Referance Notes 
Cattle  Muscle  500 
 Commission 
Regulation 
(Eu) No 
37/2010   
Liver  3000   
Kidney  2000   
Fat 1000   
Sheep  Muscle  400 Commission 
Regulation 
(Eu) No 
37/2010   
Liver  1400   
Kidney  800  
Fat 100  
Goat  Muscle  
 400 
Commission 
Regulation 
(Eu) No 
37/2010   
Liver  1400   
Kidney  800  
Fat 100  
Poultry  Muscle  
 300 
Commission 
Regulation 
(Eu) No 
37/2010   
Liver  1900   
Kidney  600  
Fat/skin  400  
 
 
Dihydrostreptomycin/ streptomycin  (Antimicrobial Drugs (مضاد الميكروبات  
Acceptable Daily Intake (ADI)  0-50 µg/kg body weight  
Residue Definition  Sum of dihydrostreptomycin and streptomycin  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
23 
 Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  600 
CAC 24 
(2001)   
Liver  600  
Kidney  1000   
Fat 600  
Milk 
(µg/l)  200 CAC 26 
(2003)   
Chicken  Muscle  600 
CAC 24 
(2001)   
Liver  600  
Kidney  1000   
Fat 600  
Sheep  Muscle  
 600 
CAC 24 
(2001)   
Liver  600  
Kidney  1000   
Fat 600  
Milk 
(µg/l)  200 CAC 26 
(2003)   
 
 
 
Diminazene  (trypanocide (مضادات الطفيليات  
Acceptable D aily Intake (ADI)  0-100 µg/kg body weight  
Residue Definition  Diminazene  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  500 
CAC 22 
(1997)   
Liver  12000   
Kidney  60000   
Milk 
(µg/l)  150 LOQ of the analytical 
method  
 
Dinitolmide    (Zoalene )  (Anticoccidial drugs  (مضاد الطفيليات  
Acceptable Daily Intake (ADI)  µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  3000  Australian 
standard MRL, 
2012  
Canadian 
MRL, 2011   
Liver  6000   
Kidney  6000   
Fat/skin  2000   
Turkey 
 Muscle  3000  Canadian 
MRL, 2011  
  
Liver  3000   
Kidney  6000   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
24 
 Fat 3000   
 
 
Doramectin  (Anthelmintic agents (مضادات الديدان  
Acceptable Daily Intake (ADI)  0-1 µg/kg body weight  
Residue Definition  Doramectin  
Species Tissue MRL (μg/kg) Referance Notes مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
25 
  
Cattle  Muscle  10 
CAC 22 
(1997)  High concentration of 
residues at the 
injection site over a 35 
day period after 
subcutaneous or 
intramuscular 
administration of the 
drug at the 
recommended dose 
Liver  100  
Kidney  30  
Fat 150 High concentrati on of 
residues at the 
injection site over a 35 
day period after 
subcutaneous or 
intramuscular 
administration of the 
drug at the 
recommended dose 
Milk 
(µg/l)  15 
CAC 29 
(2006)  Depending on the 
route and/or time of 
administration the use 
of doramectin in da iry 
cows may result in 
extended withdrawal 
periods in milk. This 
may be addressed in 
national/regional 
regulatory 
programmes.  
 
Doxapram  HCl (Nervous System Drugs (أدوية الجهاز العصبي  
Acceptable Daily Intake 
(ADI)  not established  
Species Tissue MRL (μg/k g)  Referance Notes 
All mammalian 
food producing 
species   
Not 
applicable   
No MRL 
required  Commission 
Regulation (Eu) 
No 37/2010  
  
 
 
Doxycycline  (Antimicrobial Drugs    (مضاد الميكروبات  
Acceptable Daily Intake (ADI)  0-3 μg/kg body weight  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
26 
 Species Tissue MRL (μg/kg)  Referance Notes 
Cattle  Muscle  100  
 
 
Commission 
regulation (EU) 
No 37/2010   
Liver  300  
Kidney  600  
Poultry  Muscle  100  
 
 
Commission 
regulation (EU) 
No 37/2010   
Liver  300  
Kidney  600  
Fat/skin  300  
 
Emamectin Benzoate  (antiparasi tic agent    (مضادالطفيليات  
Acceptable Daily Intake 
(ADI)  ADI of 0 –0.5 μg/kg bw established by JMPR (2011), based on 
an overall NOAEL of 0.25 mg/kg bw per day for neurotoxicity 
from 14 - and 53 -week studies in dogs, supported by an overall 
NOAEL of 0.25 mg /kg bw per day from 1 - and 2 -year studies in 
rats. An uncertainty factor of 500 was applied to the NOAEL, 
which includes an additional uncertainty factor of 5 to account 
for the steep dose –response curve and irreversible 
histopathological effects in neural  tissues at the lowest -
observed -adverse -effect level (LOAEL) in dogs, as used by 
JMPR and confirmed by JECFA78.  
 
Estimated  Dietary 
Exposure  11 μg/person per day, which represents approximately 37% of 
the upper bound of the ADI (JECFA78)  
Residue Definition  Emamectin B1a 
Species Tissue MRL (μg/kg) Referance Notes 
Salmon  Muscle  100 
CAC 38 (2015) 
  
Fillet  100 Muscle plus skin in natural 
proportion  
Trout  Muscle  100 CAC 38 (2015)   
Fillet  100 Muscle plus skin in natural 
proportion  
 
 
 
 
Enrofloxacin  (Antimicrobial Drugs    (مضاد الميكروبات  
Acceptable Daily Intake (ADI)  2 µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle 100  
  
Liver  300  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
27 
 Kidney  200  
 
 
 
Commission 
Regulation (Eu) 
No 37/2010  
  
Fat 100  
Milk 
(µg/l)  100  
Goat  Muscle  100 
Commission 
Regulation (Eu) 
No 37/2010  
  
Liver  300  
Kidney  200  
Fat 100  
Milk 
(µg/l)  100  
Poultry  Muscle  
 100 Commission 
Regulation (Eu) 
No 37/2010  
  
Liver  200  
Kidney  300  
 Fat/skin  100   
Rabbit  Muscle  100 Commission 
Regulation (Eu) 
No 37/2010  
  
Liver  200  
Kidney  300  
Fat 100  
 
Epinephrine  (Cardiovascular System Drugs (أدوية جهاز الأوعية القلبية  
Acceptable Daily Intake 
(ADI)  0.3 mg per person  
Species Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species   
Not 
applicable   
No MRL 
required  Commission 
Regulation (Eu) 
No 37/2010  
  
 
Eprinomectin  (anthelmintic agent (مضادات الديدان  
Acceptable Daily Intake (ADI)  0-10 µg/kg body weight  
Residue Definition  Eprinomectin B1a  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  
 Muscle  100 
CAC 2 6 
(2003 )  
Liver  2000   
Kidney  300  
Fat 250  
Milk 
(µg/l)  20  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
28 
  
 
ERYTHR OMYCIN  (Anti microbial  agent  (مضادالميكروبات  
Acceptable Daily Intake (ADI)  0-0.7 µg/kg body weight  
Residue Definition  Erythromycin A  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  100 
CAC 31 
(2008)  
Liver  100  
Kidney  100  
Fat 100 The MRL includes 
skin + fat  
Eggs  50  
Turkey  Muscle  100 
CAC 31 
(2008)  
Liver  100  
Kidney  100  
Fat 100 The MRL includes 
skin + fat  
 
ESTRADIOL -17BETA  (production aid (مساعد انتاج  
Acceptable Daily Intake (ADI)  unnecessary (JECFA32); 0 -0.05 μg/kg weight  
(JECFA52)  
Residue Definition  Estradiol -17beta.  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  unnecessary  
CAC 21 
(1995 )  
Liver  unnecessary   
Kidney  unnecessary   
Fat unnecessary   
 
Etamiphylline camsilat  (Respiratory System Drugs (أدوية الجهاز التنفسي  
Acceptable Daily Intake 
(ADI)  not established  
Species Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species   
Not 
applicable   
No MRL 
required  Commission 
Regulation (Eu) 
No 37/2010  
  
 
FEBANTEL/FENBENDAZOLE/OXFENDAZOLE  (anthe lmintic agent (مضادالديدان  
Acceptable Daily Intake (ADI)  Group ADI of 0 -7 μg/kg body weight  
Residue Definition  Sum of fenbendazole, oxfendazole and oxfendazole 
sulphone, expressed as oxfendazole sulphone 
equivalents  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
29 
 Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
CAC 2 3 
(1999 )  
Liver  500  
Kidney  100  
Fat 100  
Milk 
(µg/l)  100  
Goat  Muscle  100 
CAC 2 3 
(1999 )  
Liver  500  
Kidney  100  
Fat 100  
Horse  Muscle  
 100 CAC 2 3 
(1999 )  
Liver  500  
 Kidney  100   
Fat 100   
Sheep  Muscle  100 
CAC 2 3 
(1999 )  
Liver  500  
Kidney  100  
Fat 100  
Milk 
(µg/l)  100  
 
Florfenicol  (Antimicrobial Drugs    (مضاد الميكروبات  
Acceptable Daily Intake (ADI)  0-1 µg/kg body weight  
Residue Definition  Erythromycin A  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  200 Canadian MRL 
(2011)   
Liver  2000   
Kidney  500 Australian 
standard MRL, 
2012   
Fish Muscle 500 
Australian 
standard MRL, 
2012   
 
FLUAZURON  (insecticide    (مبيد حشري  
Acceptable Daily Intake (ADI)  0-40 µg/kg body weight  
Residue Definition  Fluazuron  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  200 CAC 23 
(1999 )  
Liver  500  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
30 
 Kidney  500  
Fat 7000  
 
FLUBENDAZOLE  (anthelmintic agent (مضادالديدان  
Acceptable Daily Intake (ADI)  0-12 µg/kg body weight  
Residue Definition  Flubendazole  
Species Tissue MRL (μg/kg) Referance Notes 
Poultry  Muscle  200 CAC 21  
(1995 )  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
31 
  
 Liver  500   
Eggs  400  
 
FLUMEQUINE  (Antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake (ADI)  0-30  µg/kg body weight  
Residue Definition  Flumequine  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  500 
CAC 28 
(2005)   
Liver  500  
Kidney  3000   
Fat 1000   
Chicken  Muscle  500 
CAC 28 
(2005)   
Liver  500  
Kidney  3000   
Fat 1000   
Sheep  Muscle  500 
CAC 28 
(2005)   
Liver  500  
Kidney  3000   
Fat 1000   
Trout  Muscle  500 CAC 28 
(2005)  Muscle including 
normal proportion of 
skin 
 
Flunixin m eglumine  (Anti -Inflammatories non Steroidal   مضادات الالتهابات غير
الستيرودية)  
Acceptable Daily Intake (ADI)  0-6 µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  
20 Australian 
standard MRL, 
2012,  
Canadian 
MRL(2011)   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
32 
  
 Liver  
20 Australian 
standard MRL, 
2012   Kidney  
20 
Fat 
30 Commission 
Regulation 
(EU) No 
37/2010  
Milk 
(µg/l)  6 Canadian 
MRL(2011)   
 
GENTAMICIN  (Antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake (ADI)  0-20  µg/kg body weight  
Residue Definition  Gentamicin  
Species Tissue MRL (μg/kg) Refer ance  Notes 
Cattle  Muscle  100 
CAC 2 4 
(2001)  
Liver  2000  
Kidney  5000  
Fat 100  
Milk 
(µg/l)  200  
 
GONADOTROPHIN  (Hormones  (الهرمونات  
Acceptable Daily Intake 
(ADI)  42.25 I.U. /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
All foo d 
producing 
species   
Not 
applicable   
No MRL 
required  Commission 
Regulation (Eu) 
No 37/2010  
  
 
HALOFUGINONE HYDROBROMIDE   (antiparasitic agent    (مضاد الطفيليات  
Acceptable Daily Intake (ADI)  0.0003 mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  10 Australian 
standard MRL, 
2012  
Canadian 
MRL(2011)   
Liver  30 
Kidney  30 
Fat 25 
Chicken  liver 100 Australian 
standard MRL, 
2012   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
33 
 Canadian 
MRL(2011  
 
HYDROCHLOROTHIAZIDE  (Urinary System Drugs (أدوية الجهاز البولي  
Acceptable Daily Intake 
(ADI)  12.5 mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle   
Not 
applicable   
No MRL 
required  Commission 
Regulation (Eu) 
No 37/2010  
  
 
IMIDOCARB  (antiprotozoal agent (مضادالطفيليات  
Acceptable Daily Intake (ADI)  0-10  µg/kg body weight  
Residue Definition  Flumequine  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  300 
CAC 28 
(2005)   
Liver  1500   
Kidney  2000   
Fat 50  
Milk (μg/l)  50  
 
ISOMETAMIDIUM  (Trypanocide (مضادالطفيليات  
Acceptable Daily Intake ( ADI)  0-100  µg/kg body weight  
Residue Definition  Flumequine  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  
100 
CAC 2 1 
(1995 )  
Liver  
500  
Kidney  
1000   
Fat 
100  
Milk (μg/l)  
100  
 
IVERMECTIN  (anthelmintic agent (مضادالديدان  
Accepta ble Daily Intake 
(ADI)  0-10 μg/kg bw on the basis of a NOAEL of 0.5 mg/kg bw per 
day for neurological effects (mydriasis) and retardation of 
weight gain in a 14 -week dog study, with application of an 
uncertainty factor of 50 (5 for interspecies differences  based on 
pharmacokinetic studies in dogs and humans and 10 for 
intraspecies differences). The previous ADI of 0 -1 μg/kg bw مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
34 
 was withdrawn. (JECFA81)  
Estimated Chronic 
Dietary Exposure  The estimated daily intake (EDI) is 38 μg/person per day, based 
on a 60  kg individual, which represents 6% of the upper bound 
of the ADI. The GECDE for the general population is 0.9 μg/kg 
bw per day, which represents 9% of the upper bound of the 
ADI. The GECDE for children is 1.5 μg/kg body weight per 
day, which represents 15 % of the upper bound of the ADI. The 
GECDE for infants is 1.3 μg/kg bw per day, which represents 
13% of the upper bound of the ADI. (JECFA81)  
Acute Reference Dose  0.2 mg/kg bw, based on a NOAEL of 1.5 mg/kg bw, the highest 
dose tested in a safety, tolerab ility and pharmacokinetics study 
in healthy human subjects, with application of an uncertainty 
factor of 10 for intraspecies variability. (JECFA81)  
Estimated Acute Dietary 
Exposure  A combined analysis of all studies submitted showed that after 
14 days, th e ma ximum values of residues found at injection 
sites led to a GEADE of 52 μg/kg bw for the general population 
and 87 μg/kg bw for children, corresponding, respectively, to 
27% and 43% of the ARfD. (JECFA81)  
Residue Definition  Ivermectin B1a 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  30 
CAC 40 (2017) 
  
Liver  800  
Kidney  100  
Fat 400  
Milk  10  
Sheep  Liver  15 CAC 20 (1993 ) 
  
Fat 20  
 
KETAMINE  (Nervous System Drugs (أدوية الجهاز العصبي  
Species Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species   
Not 
applicable   
No MRL 
required  Commission 
Regulation (Eu) 
No 37/2010  
  
 
KETOPROFEN  (Anti-Inflammatories non Steroidal  (مضاد الالتهابات الغير ستيرودية  
Acceptable Daily Intake (ADI)  0.001  mg/kg body weight  
Species Tissue MRL (μg/kg)  Referance Notes 
Cattle  Muscle  
50 Australian 
standard MRL, 
2012,  
Canadian  
Liver  
50  
Kidney  
50  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
35 
 Fat 
50 MRL(2011)  
  
Milk (μg/l)  
50  
 
LASALOCID SODIUM  (anthelmintic agent (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0-5 μg/kg bw on the b asis of a NOAEL of 0.5 mg/kg bw per 
day from a developmental toxicity study in rabbits and a 
multigeneration reproductive toxicity study in rats, with 
application of an uncertainty factor of 100 for interspecies and 
intraspecies variability. (JECFA78)  
Estimated Dietary 
Exposure  80 μg/person per day was calculated, which represents 
approximately 27% of the upper bound of the ADI (JECFA78)  
Residue Definition  Lasalocid A 
Note  JECFA78 extended the MRLs in chicken to turkey and quail 
and extrapolated the MRLs in chicken to pheasant.  No 
information was available for duck, including on approved uses. 
As the compound is not registered for use in laying hens, 
according to the sponsor, it is not appropriate to recommend 
MRLs for egg. 
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle 400 
CAC 40 (2017) 
  
Liver  1200   
Kidney  600  
Skin + 
fat 600  
Turkey  Muscle  400 CAC 40 (2017) 
  
Liver  1200   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
36 
  
 Kidney  600 
  
Skin + 
fat 600  
Quail  Muscle  400 
CAC 40 (2017) 
  
Liver  1200   
Kidney  600  
Skin + 
fat 600  
Pheasant  Muscle 400 
CAC 40 (2017) 
  
Liver  1200   
Kidney  600  
 Skin + 
fat 600   
 
LEVAMISOLE  (anthelmintic agent (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0-6 μg/kg body weight  
Residue Definition  Levamisole 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  10 
CAC 22 (1997 ) 
  
Liver  100  
Kidney  10  
Skin 10  
Poultry  Muscle  10 
CAC 22 (1997 ) 
  
Liver  100  
Kidney  10  
Fat 10  
Sheep  Muscle  10 
CAC 22 (1997 ) 
  
Liver  100  
Kidney  10  
Fat 10  
 
LINCOMYCIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-30 μg/kg body weight  
Residue Definition  Lincomycin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Milk  150 CAC 26 (2003 ) 
  
Chicken  Muscle  200 CAC 22 (1997 ) 
  
Liver  500  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
37 
 Kidney  500  
Fat 100 Additional MRL for skin 
with adhering fat of 300 
μg/kg  
 
LUFENURON  (insecticide (مبيد حشري  
Acceptable Daily Intake 
(ADI)  0–0.02 mg/kg bw based on the NOAEL of 1.93 mg/kg bw per 
day for tonic -clonic seizures and findings in lungs, 
gastrointestinal tract, liver and ur inary tract in a 2 -year dietary 
study in rats, and using a safety factor of 100 (10 for 
interspecies variability and 10 for intraspecies variability)  
Acute Reference Dose  Unnecessary, in view of lufenuron low acute oral toxicity and 
the absence of develop mental toxicity and other toxicological 
effects likely to be elicited by a single dose . 
Estimated Chronic 
Dietary Exposure  1.1 μg/kg bw per day (for the general population), which 
represents 5.5% of the upper bound of the ADI. As lufenuron is 
also used as  pesticide, the overall dietary exposure was 
estimated. The assumptions and detailed results will be 
displayed in the JECFA85 report. Results below are only for 
use as veterinary drug.  
Residue Definition  Lufenuron 
Species Tissue MRL (μg/kg) Referance Notes  
Salmon Fillet 1350 CAC 41 (2018 ) 
  
Trout Fillet 1350 CAC 41 (2018 ) 
  
 
MADURAMICIN AMMONIUM  (coccidial (مضاد الطفيليات  
Acceptable Daily Intake (ADI)  0.001  mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  100 Australian 
standard MRL, 
2012,  
  
Liver  1000   
Kidney  1000   
Fat /skin  400 
Canadian 
MRL(2011)  
  
 
MARBOFLOXACIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake (ADI)  4.5  µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  150 EMEA/MRL/0
79/1996   
Liver  150  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
38 
 Kidney  150 
  
Fat / 50  
Milk  75  
 
 
MEBENDAZOL  (Anthelmintic agents (مضاد الديدان  
Acceptable Daily Intake (ADI)  1.25  µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Sheep  Muscle  60  
EMEA/MRL/ 7
81/01-FINAL 
(2001 )  
 Liver  400  
Kidney  60  
Fat 60  
Goat  Liver  60  
EMEA/MRL/ 7
81/01-FINAL 
(2001 )  
Kidney  400  
Fat 60  
Liver  60  
 
MELENGESTROL ACETATE  (production aid (مساعد النمو  
Acceptable Daily Intake 
(ADI)  0-0.03 μg/kg body weight  
Resid ue Definition  Melengestrol acetate 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  1 
CAC 32 (2009 ) 
  
Liver  10  
Kidney  2  
Fat 18  
 
MEBENDAZOL (Anti-Inflammatories non Steroidal  (مضاد الالتهابات الغير ستيرودية  
Acceptable Daily Intake (AD I) 0.0001   µg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  10 Australian 
standard MRL, 
2012   
 Liver  60 Canadian 
MRL(2011)  
  
Kidney  20  
Milk 
(µg/l)  5 
Australian 
standard MRL, 
2012   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
39 
  
Methyl benzoquate  (coccidial (مضاد الطفيليات  
Acceptable Daily Intake (ADI)  0.005   mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  100 
Australian 
standard MRL, 
2012   
Liver  100  
Kidney  100  
Fat /skin  200 Canadian MRL 
(2011)   
 
MONENSIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0–10 μg/kg bw on the basis of a NOAEL of 1.14 mg/kg bw per 
day and a safety factor of 100 and rounding to one significant 
figure.  
Estimated Dietary 
Exposure  Using the revised MRL, the TMDI from JECFA70 was 
recalculated, resulting in a value of 481 μg/person, which 
represents 80% of the upper bound of the ADI  
Residue Definition  Monensin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  10 CAC 32 (2009 ) 
  
Liver  100 CAC 35 (2012 ) 
  
 Kidney  10 
CAC 32 (2009 ) 
  
Fat 100  
Milk  2  
Sheep  Muscle  10 
CAC 32 (2009 ) 
  
Liver  20  
Kidney  10  
Fat 100  
Goats  Muscle  10 
CAC 32 (2009 ) 
  
Liver  20  
Kidney  10  
Fat 100  
Chicken  Muscle  10 
CAC 32 (2009 ) 
  
Liver  10  
Kidney  10  
Fat 100  
Turke y Muscle  10 CAC 32 (2009 ) 
  
Liver  10  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
40 
 Kidney  10  
Fat 100  
Quail  Muscle  10 
CAC 32 (2009 ) 
  
Liver  10  
Kidney  10  
Fat 100  
 
MONEPANTEL  (Anthelmintic agents (مضاد الديدان  
Acceptable Daily Intake 
(ADI)  0–0.02 mg/kg bw based on the NOAEL of 1.93 mg/kg bw per 
day for tonic -clonic seizures and findings in lungs, 
gastrointestinal tract, liver and urinary tract in a 2 -year dietary 
study in rats, and using a safety factor of 100 (10 for 
interspecies variability and 10 for intraspecies variability)  
Acute Reference Dose  Unnecessary  
Estimated Dietary 
Exposure  13.7 μg per kg bw per day (for the general population), which 
represents 68% of the upper bound of the ADI  
5.0 μg per kg bw per day (for children), which represents 22% 
of the upper bound of th e ADI  
4.4 μg per kg bw per day (for infants), which represents 25% of 
the upper bound of the ADI  
Residue Definition  Monepantel sulfone, expressed as monepantel 
Species Tissue MRL (μg/kg) Referance Notes 
Sheep  Muscle  500 
CAC 38 (2015 ) 
  
Liver  7000   
Kidney  1700   
Fat 13000   
Cattle  Muscle  300 
CAC 41 (2018 ) 
  
Liver  2000   
Kidney  1000   
 Fat 7000    
 
MOXIDECTIN  (Anthelmintic agents (مضاد الديدان  
Acceptable Daily Intake 
(ADI)  0-2 μg/kg body weight  
Residue Definition  Moxidectin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  20 
CAC 22 (1997 ) 
 Very high concentration 
and great variation in the 
level of residues at the 
injection site in cattle over 
a 49 day period after 
dosing 
Liver  100  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
41 
 Kidney  50  
Fat 500  
Deer  
 Muscle  20 
CAC 23 (1999 ) 
  
Liver  100  
Kidney  50  
Fat 500  
Sheep  Muscle  50 
CAC 22 (1997 ) 
  
Liver  100  
Kidney  50  
Fat 500  
 
 
NARASIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-5 μg/kg bw on the basis of a NOAEL of 0.5 mg/kg b w per 
day and a safety factor of 100 . 
Residue Definition  Narasin A 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  15 
CAC 35 (2012 ) 
  
Liver  50  
Kidney  15  
Fat 50  
Chicken  
 Muscle  15 
CAC 32 (2009 ) 
  
Liver  50  
Kidney  15  
Fat 50  
 
NATAMYCIN  (Antifungal drugs (أدويةالمضادة للفطريات  
Acceptable Daily Intake 
(ADI)  0.3 mg  /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Edible 
tissues  Withdrawn  
(for topical use 
only)  
EMEA/MRL/342/98   
 
NEOMYCIN  (antimicrobial ag ent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-60 μg/kg body weight  
Residue Definition  Neomycin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  500 CAC 23 (1999 ) 
  
Liver  500 CAC 28 (2005 )  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
42 
 Kidney  10000    
Fat 500 CAC 23 (1999 ) 
  
Milk  1500  CAC 28 (2005 ) 
  
Chicken  
 Muscle  500 
CAC 23 (1999 ) 
  
Liver  500  
Kidney  10000   
Fat 500  
Eggs  500  
Duck  Muscle  500 
CAC 23 (1999 ) 
  
Liver  500  
Kidney  10000   
Fat 500  
Goat  Muscle  500 
CAC 23 (1999 ) 
  
Liver  500  
Kidney  10000   
 Fat 500   
Sheep  Muscle  500 
CAC 23 (1999 ) 
  
Liver  500  
Kidney  10000   
Fat 500  
Turkey  Muscle  500 CAC 23 (1999 ) 
  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
43 
  
 Liver  500 
  
Kidney  10000   
Fat 500  
 
NICARBAZIN  (antiprotozoal agent   (مضادات الطفيليات  
Acceptable Daily Intake 
(ADI)  0-400 μg/kg body weight.  
Residue Definition  , N'-bis(4-nitropheyl)urea  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  200 
CAC 23 (1999 ) 
 Broilers 
Liver  200 Broilers 
Kidney  200 Broilers 
Fat 200 Broilers 
 
NITOBIMIN  (Anthelmintic agent s (مضادالديدان  
Acceptable Daily Intake 
(ADI)  5 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
 
EMEA/MRL/56
5/99-FINAL 
(1999)   
Liver  1000   
Kidney  500  
Fat 100  
Milk  100  
Sheep  Muscle  100 
 
EMEA/MRL/56
5/99-FINAL  
(1999)   
Liver  1000   
Kidney  500  
Fat 100  
Milk  100  
Goat  Muscle  100 
 
EMEA/MRL/56
5/99-FINAL 
(1999)   
Liver  1000   
Kidney  500  
Fat 100  
Milk  100  
 
NITROXYNIL  (Anthelmintic agents (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0-20 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  1000   
Australian  
Liver  1000   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
44 
 Kidney  1000  standard MRL, 
2012   
Fat 1000   
Goat  Muscle  1000   
Australian 
standard MRL, 
2012   
Liver  1000   
Kidney  1000   
Fat 1000   
Sheep  Muscle 1000   
Australian 
standard MRL, 
2012   
Liver  1000   
Kidney  1000   
Fat 1000   
 
NITROXYNIL  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  1.25 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle   
 
Muscle   
 
100  
Australian 
standard MRL, 
2012   
Liver  100  
 Kidney  50   
Milk  100  
 
NYSTATIN  (Antifungal drugs (أدويةالمضادة للفطريات  
Acceptable Daily Intake 
(ADI)  Not established  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Edible 
tissues  Withdrawn  
(for topical use 
only)  
 
EMEA/MRL/CVMP/151/9
9  
Poultry  Edible 
tissues  Withdrawn  
(for topical use 
only)   
 
OLEANDOMYCIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0.00075 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100  
Australian 
standard MRL, 
2012   
Liver  100  
Kidney  100  
Sheep  Muscle  100  
Australian  
Liver  100  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
45 
 Kidney  100 standard MRL, 
2012   
Goat  Muscle  100  
Australian 
standard MRL, 
2012   
Liver  100  
Kidney  100  
Camel  Muscle  100  
Australian 
standard MRL, 
2012   
Liver  100  
Kidney  100  
 
ORMETOPRIM    (Anticoccidial drugs  (مضاد الطفيليات  
Acceptable Daily Intake 
(ADI)  4 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Salmon  Muscle  100  
Canadian 
MRL(2011)   
Skin 100  
 
OXYCLOZANIDE  (Anthelmintic agents (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0.03 m g/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  20 
 
EMEA/MRL/88
9/03-FINAL 
(2004)   
Liver  500  
Kidney  100  
Fat 20  
Milk  10  
Sheep Muscle  20  
EMEA/MRL/88
9/03-FINAL 
(2004)   
Liver  500  
Kidney  100  
 Fat 
 20   
 
OXYTETRACYCLINE  (Anthelmintic agents (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0-3 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100  
Australian 
standard MRL, 
2012   
Liver  300  
Kidney  600  
Milk  100 Canadian MRL 
2011   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
46 
 Goat  Muscle  100  
Australian 
standard MRL, 
2012   
Liver  300  
Kidney  600  
Milk  100  
Sheep  Muscle  
100  
Australian 
standard MRL, 
2012   
Liver  300  
Kidney  600  
Milk  100  
Camel  Muscle  100  
Australian 
standard MRL, 
2012   
milk 100  
Chicken  
 Muscle  100  
Canadian MRL 
2011   
 Liver  600 
  
Kidney  1200   
Eggs  400  
Turkey  Muscle  200  
Canadian MRL 
2011   
Liver  600  
Kidney  1200   
Salmonids 
Lobsters  Muscle 200 Canadian MRL 
2011   
Skin 200  
 
OXYTOCIN  (Antifungal drugs (أدويةالمضادة للفطريات  
FSpecies Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species  Not 
applicable   
No MRL 
required  EMEA/MRL/054/95   
 
PERMETHRIN  (Anthelmintic agents (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0.05 mg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  
50  
 
COMMISSION 
REGULATION 
(EU) NO  
Liver  
50  
Kidney  
50  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
47 
 37/2010  
Fat 
500   
 Milk  
50  
 
 
PHOXIM  (insecticide (مبيد حشري  
Accept able Daily Intake 
(ADI)  0-4 μg/kg body weight  
Residue Definition  Phoxim 
Species Tissue MRL (μg/kg) Referance Notes 
Goat  Muscle  50 
CAC 26 (2003 ) 
  
Liver  50  
Kidney  50  
Fat 400  
Sheep  Muscle  50 
CAC 26 (2003 ) 
  
Liver  50  
Kidney  50  
Fat 400  
 
PIPERAZINE  (Anthelmintic agents (مضادالديدان  
Acceptable Daily Intake 
(ADI)  0.25 mg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Eggs   
2 000  COMMISSION 
REGULATION 
(EU) NO 
37/2010   
 
Pirlimycin  (antimicrobial agent (مضادالميكر وبات  
Acceptable Daily Intake 
(ADI)  0-8 μg/kg body weight  
Residue Definition  Pirlimycin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
CAC 29 (2006 ) 
  
Liver  1000   
Kidney  400  
Fat 100  
Milk  100 JECFA  evaluated the effect 
of pirl imycin residues on 
starter cultures and for this مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
48 
 reason recommended an 
MRL of 100 μg/kg of milk. 
Codex Members may 
therefore adapt 
national/regional MRLs in 
order to address this 
technological aspect for 
trade of fresh liquid milk 
intended for processing 
using starter culture . 
 
POLOXALENE  (Digestive System Drugs   (أدوية الجهاز الهضمي  
Acceptable Daily Intake 
(ADI)  0.02 mg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species  Not 
applicable  No MRL 
required  COMMISSION 
REGULA TION 
(EU) No 37/2010   
 
POLYMIXIN  B (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  4.0 u/ml body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Milk   
4000 U/ml  Canadian 
MRL(2011)   
 
PRAZEQUANTEL   (Anthelmintic agents (مضاد الديدان  
Acceptable Daily Intake 
(ADI)  0-20 μg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Sheep  Muscle  
50 Australian 
standard MRL, 
2012  
  
Liver  
50  
Kidney  
50  
Fat 
50  
 
PREDNISOLONE  (glucocorticosteroid   (مضادات الالتهابات الستيرودية  
Acceptable Daily Intake 
(ADI)  0.0002 mg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  
4   مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
49 
 Liver  
10  
 
COMMISSION 
REGULATION 
(EU) No 
37/2010   
Kidney  
10  
Fat 
4  
Milk  
6  
 
PROCAINE BENZYL PENICILLIN  (antimicrobial  agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  30 μg penicillin/person/day  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 
Australian 
standard MRL, 
2012   
Liver  50  
Kidney  50  
Milk  1.5  
 
Procaine HCl  (Nervous System Drugs (أدوية الجهاز العصبي  
Acceptable Daily Intake 
(ADI)  not established  
Species Tissue MRL (μg/kg) Referance Notes 
All food 
producing 
species  Not 
applicable  No MRL 
required  COMMISSION 
REGULATION 
(EU) No 37/2010   
 
PROGESTERONE  (production aid (مساعد انتاج  
Acce ptable Daily Intake 
(ADI)  0-30 μg/kg body weight  
Residue Definition  Progesterone 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  unnecessary  
CAC 21 (2005 ) 
 Residues resulting from the 
use of this substances as a 
growth promoter in 
accordance wi th good 
animal husbandry practice 
are unlikely to pose a 
hazard to human health .  Liver  unnecessary  
Kidney  unnecessary  
Fat unnecessary  
 
RACTOPAMINE  (production aid (مساعد انتاج  
Acceptable Daily Intake 
(ADI)  0-30 μg/kg body weight  
Residue Defi nition  Ractopamine 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  10 CAC 35 (2012 )  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
50 
 Liver  40  
Kidney  90 
Fat 10 
 
RAFOXANIDE   (Anthelmintic agents (مضادالديدان  
Acceptable Daily Intake 
(ADI)  2 μg/kg body weight  
Species Tissue MRL ( μg/kg)  Referance Notes 
Cattle  Muscle  30 
EMEA/MRL/63
6/99 
FINAL (1999)   
Liver  10  
Kidney  40  
Fat 30  
Sheep  Muscle  100 
EMEA/MRL/63
6/99 
FINAL (1999)   
Liver  150  
Kidney  150  
Fat 250  
 
ROBENIDINE HYDROCHLORIDE    (Anticoccidial drugs  (مضاد الطفيليات  
Acceptable Daily Intake 
(ADI)  0.005 mg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  100 Canadian 
MRL(2011)  
Australian 
standard MRL, 
2012   Liver  100 
Kidney  100 
Fat 
/skin  200 Canadian 
MRL(2011)   
 
 
 
ROXARSONE  (Growth Promoting Agent  (محفز النمو  
Acceptable Daily Intake 
(ADI)  25 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  500 
Canadian 
MRL(2011)  
  
Liver  200  
Eggs  500  
Turkey  Muscle  
500 Canadian 
MRL(2011)  
  
Liver  
200  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
51 
  
SALINOMYCIN  SODIUM    (Anticoccidial drugs  (مضاد الطفيليات  
Acceptable Daily Intake 
(ADI)  0.01 mg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 Australian 
standard MRL, 
2012   
Liver  350 Canadian 
MRL(2011)   
Kidney  500 Austra lian 
standard MRL, 
2012   
Chicken  Muscle  100 Australian 
standard MRL, 
2012   
Liver  500  
Kidney  500  
Fat 350 Canadian 
MRL(2011)   
Eggs  20 Australian 
standard MRL, 
2012   
 
SARAFLOXACIN  (insecticide (مبيد حشري  
Acceptable Daily Intake 
(ADI)  0-0.3 μg/k g body weight  
Residue Definition  Sarafloxacin 
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  10 
CAC 24 (2001 ) 
  
Liver  80  
Kidney  80  
Fat 20  
Turkey  Muscle  10 
CAC 24 (2001 ) 
  
Liver  80  
Kidney  80  
Fat 20  
 
SEMDURAMICIN  (Anticoccidial drugs  (مضاد الطفيليات  
Acceptable Daily Intake 
(ADI)  3 ug/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  50 National 
Registration 
Authority   
Liver  500  
Kidney  200  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
52 
 Fat 
/skin  500 for Agricultural 
and Veterinary 
Chemicals, 
Australia, 2001   
 
SPECTINOMYCIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-40 μg/kg body weight  
Residue Definition  Spectinomycin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  500 
CAC 23 (1999 ) 
  
Liver 2000   
Kidney  5000   
Fat 2000   
Milk 
μg/l 200  
Chicken  Muscle  500 
CAC 23 (1999 ) 
  
Liver  2000   
Kidney  5000   
Fat 2000   
Eggs  2000   
Sheep  Muscle  500 
CAC 23 (1999 ) 
  
Liver  2000   
Kidney  5000   
Fat 2000   
 
SPIRAMYCIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-50 μg/kg body weight  
Residue Definition  Cattle and chickens, sum of spi ramycin and neospiramycin;  
spiramycin equivalents  antimicrobially active residues .  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  200 
CAC 22 (1997 ) 
  
Liver  600  
Kidney  300  
Fat 300  
Milk 
μg/l 200  
Chicken  Muscle  200 
CAC 22 (1997 ) 
  
Liver  600  
Kidney  800  
Fat 300  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
53 
  
STREPTOMYCIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-50 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  300  
Australian 
standard MRL, 
2012   
Liver  300  
Kidney  300  
Fat 500  
Canadian MRL, 
2011   
 Milk 
(µg/l)  125   
Goat  Muscle  300 
Australian 
standard MRL, 
2012  
  
Liver  300  
Kidney  300  
Milk  
(µg/l)  200  
Sheep  Muscle  300  
Australian 
standard MRL, 
2012   
Liver  300  
Kidney  300  
Fat 600  
Milk  
(µg/l)  200   
Camel  Muscle  100  
Australian 
standard MRL, 
2012   
milk 100  
Camel  
 Muscle  300 
Australian 
standard MRL,  
2012   
Liver  300  
Kidney  300  
Milk 
(µg/l)  200  
 
SULFADIMIDINE  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-50 μg/kg body weight  
Residue Definition  Sulfadimidine 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Milk 
μg/l 25 CAC 21 (1995 ) 
  
Not specified  Muscle  100 CAC 21 (1995)   
Liver  100  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
54 
 Kidney  100  
Fat 100  
 
TEFLUBENZURON  (insecticide    (مبيد حشري  
Acceptable Daily Intake 
(ADI)  0-5 μg/kg bw on the basis of a lower 95% confidence limit on 
the benchmark dos e for a 10% response (BMDL10) of 0.54 
mg/kg bw per day for hepatocellular hypertrophy in male mice 
observed in a carcinogenicity study, with application of an 
uncertainty factor of 100 to account for interspecies and 
intraspecies variability.  
Estimated Chronic 
Dietary Exposure  The EDI is 42.9 μg/person per day, on the basis of a 60 kg 
individual, which represents approximately 14% of the upper 
bound of the ADI. The GECDE for the general population is 
1.6 μg/kg bw per day, which represents 31% of the upper 
bound of the ADI. The GECDE for children is 2.1 μg/kg bw 
per day, which represents 43% of the upper bound of the ADI. 
The GECDE for infants is 0.9 μg/kg bw per day, which 
represents 18% of the upper bound of the ADI.  
Residue Definition  Teflubenzuron 
Spec ies  Tissue MRL (μg/kg) Referance Notes 
Salmon  Muscle  400 CAC 40 (2017 ) 
  
Fillet  400 Muscle plus skin in natural 
proportion  
 
 
TESTOSTERONE  (production aid (مساعد انتاج  
Acceptable Daily Intake 
(ADI)  0-2 μg/kg body weight  
Residue Definition  Testosteron e  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  unnecessary  
CAC 21 (1995)  Residues resulting from the 
use of this substances as a 
growth promoter in 
accordance with good 
animal husbandry practice 
are unlikely to pose a 
hazard to human health . Liver  unnecessary  
Kidney  unnecessary  
Fat unnecessary  
 
TETRACYCLINE  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-3 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100  
COMMISSION  
Liver  300  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
55 
 Kidney  600 REGULATION  
(EU) No 
37/2010  
  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
56 
  
 Fat 100   
Milk 
(µg/l)  100  
Goat  Muscle  100 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  300  
Kidney  600  
Milk  
(µg/l)  100  
Sheep  Muscle  100 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  300  
Kidney  600  
 Milk  
(µg/l)  100   
Chicken  Muscle  100 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  300  
Kidney  600  
Eggs  200  
 
THIABENDAZOLE  (Anthelmintic agent    (مضاد الديدان  
Acceptable Daily Intake 
(ADI)  0-100 μg/kg body weight  
Residue  Definition  Sum of thiabendazole and 5 -hydroxythiabendazole  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
CAC 21 (1995 ) 
 The MRL also covers 
residues derived from feed 
containing the residues 
resulted from agricultural 
use. Liver  100 
Kidney  100 
Fat 100 
Milk 
μg/l 100 
Goat  Muscle  100 
CAC 21 (1995 ) 
 The MRL also covers 
residues derived from feed 
containing the residues 
resulted from agricultural 
use. Liver  100 
Kidney  100 
Fat 100 
Milk 
μg/l 100 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
57 
  
Sheep  Muscle  100 
CAC 21 (1995 ) 
 The MRL also covers 
residues derived from feed 
containing the residues 
resulted from agricultural 
use. Liver  100 
Kidney  100 
Fat 100 
 
THIAMPHENICOL  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-1 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  50 
Kidney  50 
Fat 50 
Milk 
μg/l 50 
Goat  Muscle  50 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  50 
Kidney  50 
Fat 50 
Milk 
μg/l 50 
Sheep  Muscle  50 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  50 
Kidney  50 
Fat 50 
Milk 
(µg/l)  50  
 
TIAMULIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-30 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Chicken  Muscle  100 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  1000  
Fat/skin  100 
Eggs  1000  
Turkey  Muscle  100 COMMISSION 
REGULATION 
(EU) No 
37/2010  
  
Liver  300 
Fat/skin  100 
Rabbit  Muscle  100 COMMISSION 
REGULATION  
Liver  500 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
58 
 (EU) No 
37/2010  
 
 
TILMICOSIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-40 μg/kg body weight  
Residue Definition  Tilmicosin 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
CAC 23 (1999 ) 
  
Liver  1000 
Kidney  300 
Fat 100 
Chicken  Muscle  150 
CAC 36 (2011 ) 
  
Liver  2400 
Kidney  600 
Skin/ Fat 250 
Sheep  Muscle  100 
CAC 23 (1999 ) 
  
Liver  1000 
Kidney  300 
Fat 100 
Turkey  Muscle  100 
CAC 34 (2011 ) 
  
Liver  1200   
Kidney  1400   
Skin/Fat  250  
 
TOLFENAMIC  ACID  (Anti -Inflammatories non Steroidal    (مضادات الالتهابات غير 
الستيرودية  
Acceptable Daily Intake 
(ADI)  0-0.1 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50 
EMEA/MRL/18
3/97 
FINAL  (1997)   
Liver  400 
Kidney  100 
Milk 
(µg/l)  50 
 
TOLTRAZURIL   (Anticoccidial drugs  (مضادالطفيليات  
Acceptable Daily Intake 
(ADI)  0-2 μg/kg body weight  
Residue Definition  Toltrazuril 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  250  
Australian 
standard MRL,  
Liver  2000  
Kidney  1000  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
59 
 Fat 1000  2012  
Chicken  Muscle  2000   
Australian 
standard MRL, 
2012   
Liver  5000  
Kidney  5000  
Eggs  30 
 
TRENBOLONE  ACETATE  (Growth Promoting Agent (محفز النمو  
Acceptable Daily Intake 
(ADI)  0-0.2 μg/kg body weight  
Residue Definition  Cattle muscle, beta -Trenbolone; Cattle liver, alpha -Trenbolone  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  2 CAC 21 (1995)  
  
Liver  10 
 
TRICAINE METHANESULFONATE  (Nervous System Drugs (أدوية الجهاز العصبي  
Acceptable Daily Intake 
(ADI)  not established  
Species Tissue MRL (μg/kg) Referance Notes 
 
Salmonids  Muscle  10  
Canadian 
MRL(2011 )  
Skin 10 
 
TRICHLORFON  (Metrifonate ((insecticide    (مبيد حشري  
Acceptable Daily Intake 
(ADI)  0-2 μg/k g body weight  
Residue Definition  JECFA54 confirmed the MRL for cows’s milk and the guidance 
levels for muscle, liver, kidney and fat of cattle recommended 
(WHO TRS 900, 2001 )  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Milk  50 CAC 2 9 (2008 ) 
  
 
TRICLABENDAZOLE  (Anthelmintic agent    (مضاد الديدان  
Acceptable Daily Intake 
(ADI)  0-3 μg/kg body weight  
Residue Definition  Ketotriclabnedazole 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  250 
CAC 32 (2009)   
Liver  850 
Kidney  400 
Fat 100 
Sheep  Muscle  200 
CAC 32 (2009)   
Liver  300 
Kidney  200 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
60 
 Fat 100 
 
TRIMETHOPRIM  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  20 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  50  
 
Austral ian 
standard MRL, 
2012   
Liver  50 
Kidney  50 
Fat 50 
Milk 
μg/l 50 
Goat  Muscle  50  
 
Australian 
standard MRL, 
2012   
Liver  50 
Kidney  50 
Fat 50 
Milk 
μg/l 50 
Sheep  Muscle  50  
 
Australian 
standard MRL, 
2012   
Liver  50 
Kidney  50 
Fat 50 
Milk 
(µg/l)  50  
 
TRIMETHOPRIM  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0.005 mg /kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 
Australian standard 
MRL, 2012   
Liver  2000  Canadia n MRL 2011  
Kidney  1000  Australian standard 
MRL, 2012  Fat 100 
 
TYLOSIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  0-30 μg/kg bw based on a microbiological end -point derived 
from in vitro MIC susceptibility testing and faec al binding data 
(MICcalc = 1.698)  
Residue Definition  Tylosin A 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100 CAC 32 (2009 ) 
  
Liver  100 
Kidney  100 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
61 
 Fat 100 
Milk  100  
Chicken  Muscle  100 
CAC 32 (2009 ) 
  
Liver  100 
Kidney  100 
Skin/Fa
t 100 
Eggs  300  
 
VIRGINIAMYCIN  (antimicrobial agent (مضادالميكروبات  
Acceptable Daily Intake 
(ADI)  250 μg/kg body weight  
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  100  
 
Australian 
standard MRL, 
2012   
Liver  200 
Kidney  200 
Fat 200 
Milk 
μg/l 100 
Chicken  Muscle  200  
 
Australian 
standard MRL, 
2012   
Liver  200 
Kidney  200 
Fat 
/skin  200 
Eggs  100  
 
ZERANOL  (Growth Promoting Agent (محفز النمو  
Acceptable Daily Intake 
(ADI)  0-0.5 μg/kg body weight  
Residue Definition  Zeranol 
Species Tissue MRL (μg/kg) Referance Notes 
Cattle  Muscle  2 CAC 21 (1995 ) 
  
Liver  10 
 
ZILPATEROL  (Growth Promoting Agent  (محفز النمو  
Acceptable Daily Intake 
(ADI)  0.083  μg/kg body weight  
Species Tissue MRL (μg/kg) Refera nce  Notes 
Cattle  Muscle  2 Canadian 
MRL(2011)  
  
Liver  5 
Kidney  5 
 
  
 مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
62 
 المراجع:  
 ACCEPTABLE DAILY INTAKES (ADI) FOR AGRICULTURAL AND 
VETERINARY CHEMICALS. Australian Government, Department of Health and 
Aging Office of Chemical Safety. 31 December 2012.  
 Australian Standard (2012), Australian Pesticides and Veterinary Medicines Authority,  
The MRL Standard,  Maximum residue limits in food and animal feedstuff July 2012.  
 Canadian Standards, Maximum residue lim its (MRLs) of veterinary drugs in food, 
2011.  
 Codex  Alimentarius Commission (CAC), Maximum residue limits (MRLs) of 
veterinary drugs in food CX/MRL 2 -2018 . 
 COMMISSION REGULATION (EU) No 37/2010  
 COUNCIL REGULATION (EEC) No 2377/90  
 http://www.fve.org/veteri nary/pdf/medicines/regulation_2377_90_en.pdf  
 EMEA/MRL/865/03 -FINAL, June 2004 : The European Agency for the Evaluation of 
Medicinal products.  Veterinary Medicines and Information Technology Unit.  
 EMEA/MRL/CVMP/151/99 -FINAL, March 1999. The European Agenc y for the 
Evaluation of Medicinal products.  Veterinary Medicines and Information Technology 
Unit. Committee for Veterinary Medical Products.  
 EMEA/MRL/889/03 -FINAL. June 2004. The European Agency for the Evaluation of 
Medicinal products.  Veterinary Medici nes and Information Technology Unit. 
Committee for Veterinary Medical Products.  
 EMEA/MRL/342/00 -FINAL. January 2001. The European Agency for the Evaluation 
of Medicinal products.  Veterinary Medicines and Information Technology Unit. 
Committee for Veterina ry Medical Products.  
 EMEA/MRL/565/99 -FINAL April (1999). The European Agency for the Evaluation 
of Medicinal products.  Veterinary Medicines and Information Technology Unit. 
Committee for Veterinary Medical Products.  
 EMEA/MRL/342/98 -FINAL. February 1998. T he European Agency for the 
Evaluation of Medicinal products.  Veterinary Medicines and Information Technology 
Unit. Committee for Veterinary Medical Products.  
 EUROPEAN COMMUNITY COMMENTS ON CODEX CIRCULAR LETTER CL 
2005 -10 RVDF.  مواصفة  قياسية خليجية  GSO  2481/2019  
  
 
 
63 
  EMEA/MRL/079/96 -FINAL, Marc h 1996. The European Agency for the Evaluation 
of Medicinal products.  Veterinary Medicines and Information Technology Unit.  
 